3.0.0 4103 2023-01-13T04:49:53Z 2023-01-13T04:49:53Z House H HR 2005-10-20 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-11-04T21:56:11Z Referred to 2005-10-20T13:56:16Z hswm00 Ways and Means Committee House Standing Referred to 2005-10-20T13:56:21Z 2005-11-04 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-10-20 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hswm00 Ways and Means Committee 2005-10-20 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-10-20 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-10-20 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-10-20 Introduced in House IntroReferral 1000 9 Library of Congress B000944 Rep. Brown, Sherrod [D-OH-13] Sherrod Brown D OH 13 N D000355 Rep. Dingell, John D. [D-MI-15] JOHN DINGELL D MI D. 15 2005-10-20 True R000053 Rep. Rangel, Charles B. [D-NY-15] CHARLES RANGEL D NY B. 15 2005-10-20 True W000215 Rep. Waxman, Henry A. [D-CA-30] HENRY WAXMAN D CA A. 30 2005-10-20 True S000810 Rep. Stark, Fortney Pete [D-CA-13] PETE STARK D CA 13 2005-10-20 True S001145 Rep. Schakowsky, Janice D. [D-IL-9] JANICE SCHAKOWSKY D IL D. 9 2005-10-20 True Health Access to health care Auditing Business records Coinsurance Commerce Congress Congressional reporting requirements Consumer complaints Consumer education Cost accounting Drug industry Drugs Federal employees Finance and Financial Sector Financial statements Government Operations and Politics Government contractors Government employees' health insurance Government paperwork Health insurance Health maintenance organizations Inspectors general Insurance premiums Investments Legislation Managed care Medicaid Medical economics Medical fees Medical statistics Medicare Medigap Ombudsman Physicians Prescription pricing Profit Social Welfare Health 00 2005-10-20 Introduced in House 2005-11-30T20:46:57Z Medicare Advantage and Prescription Drug Accountability Act of 2005 - Amends title XVIII (Medicare) of the Social Security Act to require the contract with an Medicare Advantage (MA) organization to provide for a minimum loss ratio (aggregate average benefits that are at least a minimum ratio of the aggregate average revenues collected under the contract) and a maximum administrative cost ratio (aggregate average administrative costs that do not exceed a maximum ratio of the aggregate average revenues collected under the contract).

Requires each contract with a Medicare+Choice organization to grant the Secretary of Health and Human Services the right to audit and inspect any books and records of the organization for compliance with such ratio and related administrative cost requirements.

Applies such requirements to contracts with prescription drug sponsors under Medicare part D (Voluntary Prescription Drug Benefit Program).

Prescribes requirements for financial transparency of MA plans.

Renders an election to enroll with an MA plan ineffective unless the election form is signed by the individual and specifically acknowledges specified plan features.

Applies such requirements to prescription drug plans under Medicare part D.

Directs the Secretary to transmit to Congress annual MA accountability and prescription drug accountability reports.

Requires periodic audits by the departmental Inspector General of the Secretary's determinations about the acturial equivalency of MA plans.

Requires each prescription drug plan sponsor with respect to a prescription drug plan, and each MA organization with respect to an MA-PD plan, to report annually to the Inspector General on drug claims rejections and reversals on appeal.

Directs the Secretary to appoint a Medicare prescription drug ombudsman.

]]> Medicare Advantage and Prescription Drug Accountability Act of 2005 Display Title Medicare Advantage and Prescription Drug Accountability Act of 2005 Official Title as Introduced To amend title XVIII of the Social Security Act to provide for improved accountability in the Medicare Advantage and prescription drug programs. Introduced in House IH Short Titles as Introduced Medicare Advantage and Prescription Drug Accountability Act of 2005 Introduced in House 2005-10-20T04:00:00Z 2005-11-04 Referred to the Subcommittee on Health. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.